GeneDx Holdings

WGS · NASDAQ

$68.74+$2.45 (+3.70%)TodayMarket closed ·
Prev close $66.29

Latest news

  • Press releaseBusiness Wire

    GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

  • Press releaseBusiness Wire

    GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026

  • Press releaseBusiness Wire

    GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026

  • Press releaseBusiness Wire

    GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care

  • Press releaseBusiness Wire

    GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C

  • Press releaseBusiness Wire

    GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree

  • NewsErica Kollmann

    Short Sellers Are All-In on These 10 Stocks — Squeeze Watch List Inside

  • Press releaseBusiness Wire

    GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s

  • Press releaseBusiness Wire

    GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

  • Press releaseBusiness Wire

    GeneDx to Participate in Upcoming Investor Conferences

  • News

    CORRECTION: GeneDx Hldgs Q2 Adj. EPS $0.01 Beats $(0.19) Estimate, Sales $114.440M Beat $111.011M Estimate

  • Press releaseBusiness Wire

    GeneDx Reports Second Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

  • Press releaseGlobe Newswire

    WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law

  • Press releasePRNewswire

    DEADLINE TODAY: GeneDx Holdings Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - WGS

  • Press releasePRNewswire

    DEADLINE TODAY: GeneDx Holdings Corp. Investor Alert: Contact SBS by August 3, 2026 for Opportunity to Lead Securities Fraud Lawsuit

  • Press releasePRNewswire

    WGS Deadline: WGS Investors with Losses in Excess of $100K Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

  • Press releaseBusiness Wire

    GeneDx Holdings Corp. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

  • Press releaseGlobe Newswire

    GENEDX HOLDINGS DEADLINE MONDAY AUGUST 3rd: Bragar Eagel & Squire, P.C. Urges GeneDx Holdings Corp. Investors to Contact the Firm Regarding Lead Plaintiff Deadline

  • Press releaseGlobe Newswire

    MONDAY DEADLINE: GeneDx Holdings Corp. (WGS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

  • Press releaseGlobe Newswire

    WGS 4-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

  • Press releasePRNewswire

    SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. Lawsuit - WGS

  • Press releaseNewsfile

    GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

  • Press releaseGlobe Newswire

    WGS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

  • Press releasePRNewswire

    Levi & Korsinsky Reminds GeneDx Holdings Corp. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 3, 2026 - WGS

  • Press releaseGlobe Newswire

    GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS

  • Press releaseGlobe Newswire

    WGS 6-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

  • Press releaseGlobe Newswire

    Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); GeneDx Holdings Corp. (NASDAQ: WGS); Navan, Inc. (NASDAQ: NAVN); and New Era Energy & Digital, Inc. (NASDAQ: NUAI) (FKA New Era Helium (NASDAQ: NEHC)): Grabar Law Office is Investigating Claims on Your Behalf

  • News

    10 Health Care Stocks Whale Activity In Today's Session

  • NewsAvi Kapoor

    Crude Oil Down 4%; PayPal Shares Fall After Q1 Results

  • NewsAvi Kapoor

    Dow Jumps Over 300 Points; Pfizer Posts Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.